367 related articles for article (PubMed ID: 21151872)
41. Survival and biodistribution of xenogenic adipose mesenchymal stem cells is not affected by the degree of inflammation in arthritis.
Toupet K; Maumus M; Luz-Crawford P; Lombardo E; Lopez-Belmonte J; van Lent P; Garin MI; van den Berg W; Dalemans W; Jorgensen C; Noël D
PLoS One; 2015; 10(1):e0114962. PubMed ID: 25559623
[TBL] [Abstract][Full Text] [Related]
42. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
[TBL] [Abstract][Full Text] [Related]
43. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
[TBL] [Abstract][Full Text] [Related]
44. Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism.
Rozenberg A; Rezk A; Boivin MN; Darlington PJ; Nyirenda M; Li R; Jalili F; Winer R; Artsy EA; Uccelli A; Reese JS; Planchon SM; Cohen JA; Bar-Or A
Stem Cells Transl Med; 2016 Nov; 5(11):1506-1514. PubMed ID: 27400792
[TBL] [Abstract][Full Text] [Related]
45. Anti-inflammatory and antitumoural effects of Uncaria guianensis bark.
Urdanibia I; Michelangeli F; Ruiz MC; Milano B; Taylor P
J Ethnopharmacol; 2013 Dec; 150(3):1154-62. PubMed ID: 24212077
[TBL] [Abstract][Full Text] [Related]
46. PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis.
Luz-Crawford P; Ipseiz N; Espinosa-Carrasco G; Caicedo A; Tejedor G; Toupet K; Loriau J; Scholtysek C; Stoll C; Khoury M; Noël D; Jorgensen C; Krönke G; Djouad F
Ann Rheum Dis; 2016 Dec; 75(12):2166-2174. PubMed ID: 26964143
[TBL] [Abstract][Full Text] [Related]
47. Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis.
Silva JD; Lopes-Pacheco M; de Castro LL; Kitoko JZ; Trivelin SA; Amorim NR; Capelozzi VL; Morales MM; Gutfilen B; de Souza SAL; Weiss DJ; Diaz BL; Rocco PRM
Stem Cell Res Ther; 2019 Aug; 10(1):264. PubMed ID: 31443678
[TBL] [Abstract][Full Text] [Related]
48. SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production.
Zhang L; Dang RJ; Li H; Li P; Yang YM; Guo XM; Wang XY; Fang NZ; Mao N; Wen N; Jiang XX
PLoS One; 2014; 9(5):e97256. PubMed ID: 24826993
[TBL] [Abstract][Full Text] [Related]
49. IFNγ and TNFα synergistically induce apoptosis of mesenchymal stem/stromal cells via the induction of nitric oxide.
Li X; Shang B; Li YN; Shi Y; Shao C
Stem Cell Res Ther; 2019 Jan; 10(1):18. PubMed ID: 30635041
[TBL] [Abstract][Full Text] [Related]
50. Gilz-Activin A as a Novel Signaling Axis Orchestrating Mesenchymal Stem Cell and Th17 Cell Interplay.
Luz-Crawford P; Espinosa-Carrasco G; Ipseiz N; Contreras R; Tejedor G; Medina DA; Vega-Letter AM; Ngo D; Morand EF; Pène J; Hernandez J; Jorgensen C; Djouad F
Theranostics; 2018; 8(3):846-859. PubMed ID: 29344311
[TBL] [Abstract][Full Text] [Related]
51. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
[TBL] [Abstract][Full Text] [Related]
52. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
53. Adipose-derived mesenchymal stem cells modulate CD14
Qiu G; Zheng G; Ge M; Huang L; Tong H; Chen P; Lai D; Hu Y; Cheng B; Shu Q; Xu J
Stem Cell Res Ther; 2017 Apr; 8(1):97. PubMed ID: 28446249
[TBL] [Abstract][Full Text] [Related]
54. Prostaglandin E2 and Transforming Growth Factor-β Play a Critical Role in Suppression of Allergic Airway Inflammation by Adipose-Derived Stem Cells.
Cho KS; Lee JH; Park MK; Park HK; Yu HS; Roh HJ
PLoS One; 2015; 10(7):e0131813. PubMed ID: 26176545
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow mesenchymal stem cells suppress IL-9 in adjuvant-induced arthritis.
Abd-Elhalem SS; Haggag NZ; El-Shinnawy NA
Autoimmunity; 2018 Feb; 51(1):25-34. PubMed ID: 29359591
[TBL] [Abstract][Full Text] [Related]
56. Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice.
Zhou X; Hua X; Ding X; Bian Y; Wang X
J Clin Immunol; 2011 Jun; 31(3):395-405. PubMed ID: 21305388
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic effect of low-dose IL-18 combined with IL-10 on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of Th2 responses.
Dai Q; Li Y; Zhang F; Yu H; Wang X
Rheumatol Int; 2009 Apr; 29(6):615-22. PubMed ID: 18841371
[TBL] [Abstract][Full Text] [Related]
58. A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
Chen Q; Muramoto K; Masaaki N; Ding Y; Yang H; Mackey M; Li W; Inoue Y; Ackermann K; Shirota H; Matsumoto I; Spyvee M; Schiller S; Sumida T; Gusovsky F; Lamphier M
Br J Pharmacol; 2010 May; 160(2):292-310. PubMed ID: 20423341
[TBL] [Abstract][Full Text] [Related]
59. Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-κB, MAPK and AP-1 signaling pathways in macrophages.
Shi Q; Cao J; Fang L; Zhao H; Liu Z; Ran J; Zheng X; Li X; Zhou Y; Ge D; Zhang H; Wang L; Ran Y; Fu J
Int Immunopharmacol; 2014 Jun; 20(2):298-306. PubMed ID: 24735815
[TBL] [Abstract][Full Text] [Related]
60. iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.
Maria ATJ; Rozier P; Fonteneau G; Sutra T; Maumus M; Toupet K; Cristol JP; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():3056. PubMed ID: 30622540
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
